Mechanisms of sleep induction by GABA(A) receptor agonists.
Level 5 - mechanism / opinion, no new human data
Narrative review of basic neuropharmacology and receptor mechanisms
What was done
Narrative review of GABA(A) receptor neurobiology, detailing synaptic versus extrasynaptic receptor configurations, subunit heterogeneity across 19 cloned subunits, and the differential pharmacological responsiveness of distinct pentameric receptor complexes to sedative-hypnotic agents.
What was found
The abstract reports mechanistic pharmacological classifications rather than quantitative clinical data (no empirical numbers or statistics are reported). Synaptic receptors containing alpha1, alpha2, or alpha3 with gamma2 mediate phasic inhibition and are sensitive to benzodiazepines and zolpidem. Extrasynaptic receptors containing alpha4 or alpha6 with delta, or alpha5, mediate tonic inhibition with higher GABA affinity and slower desensitization, remaining insensitive to benzodiazepines and zolpidem but responsive to ethanol and gaboxadol (THIP).
Why it matters
Characterizing GABA(A) receptor subunit diversity clarifies how traditional benzodiazepine-site hypnotics differ mechanistically from compounds that induce sleep via extrasynaptic receptors.
Limits
This is a narrative review with no original clinical trial data, systematic search protocol, or quantitative statistical measures. It reflects preclinical and molecular neuropharmacology rather than clinical patient outcomes.
Cited by
- supports Sedative-hypnotic sleep aids such as Ambien exert their sedative effects by acting on GABA receptors.